Professor Jonathan Golledge is Head of the Queensland Research Centre for Peripheral Vascular Disease and its pre-clinical arm The Vascular Biology Unit (VBU) at the School of Medicine and Dentistry, James Cook University. Professor Golledge joined JCU in 2002 and established the Vascular Biology Unit with the aim of carrying out research intended to be translated into improved management of aortic aneurysm and other peripheral vascular conditions. We continue to seek high quality students and researchers to join our group. Trained as a vascular specialist, Professor Golledge took 2 years out of specialist training to obtain experience in research techniques as part of a Cambridge MChir (Doctoral equivalent), UK. His research commitment is illustrated by a large number of presentations at International and National meetings and publications in peer-reviewed journals, including a large number in top specialised journals.

Professor Golledge holds a conjoint position between the School of Medicine and Dentistry and Queensland Health, where he works as a vascular surgeon. In addition to providing a high quality clinical service his principal aspiration is to improve management of peripheral vascular diseases. The research impact of this is evidenced by external grant support from the NIH, NHMRC, Queensland Government, NHF and other bodies. Of note in 2010 Professor Golledge led a successful bid to establish a NHMRC funded centre of research excellence for Peripheral Vascular Disease.

Research Disciplines
Socio-Economic Objectives
  • 2002 - Fellow of the Royal Australasian College of Surgeons
  • 1994 - Fellow of the Royal College of Surgeons of England
  • 2012 - Editorial board member, Arteriosclerosis, Thrombosis and Vascular Biology
  • 2009 - Member of The Australian and International Stroke Genetics Collaboration
  • 2009 - Member of The Research Committee of the Faculty Medicine, Health and Molecular Sciences
  • 2007 - Member of the Board of Surgical Research of the Royal Australasian College of Surgeons
  • 2002 - Member of the Australian Vascular Biology Society
  • 2002 - Member of the School of Medicine Research Committee, James Cook University
  • 1996 - Member of the European Society of Vascular Surgery
  • 2002 to 2009 - Member of the ethics committee, The Mater Hospital, Townsville
  • 2003 to 2004 - Member of the Biological Sciences selection panel for internal grants, James Cook University
  • 1996 to 2001 - Member of the Vascular Surgical Society of Great Britain and Ireland
  • 2012 - Editorial board Arteriosclerosis, Thrombosis and Vascular Biology
  • 2011 - Credentialling Committee The Townsville Hospital
  • 2007 - Editorial board member Atherosclerosis
  • 2003 - Reviewer The Lancet, Circulation, Arteriosclerosis, Thrombosis and Vascular Biology, Atherosclerosis, Journal of Vascular Surgery, European Journal of Vascular and Endovascular Surgery, American Journal of Cardiology, American Journal of Pathology
  • 2003 - External reviewer for numerous granting bodies including the National Health and Medical Research Council, National Heart Foundation and other international funding bodies such as the Welcome Trust
  • 2002 - Chairman of the Austalian and New Zealand Society of Vascular Surgery Research Group
  • 2000 - Reviewer Stroke
  • 1997 - Reviewer The Journal of Vascular Surgery and the European Journal of Vascular and Endovascular Surgery
  • 2003 to 2009 - Language Editor European Journal of Vascular and Endovascular Surgery
  • 2002 to 2007 - Chairman of the BMedSci Committee, James Cook University

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

ResearchOnline@JCU stores 328+ research outputs authored by Prof Jon Golledge from 2003 onwards.

Current Funding

Current and recent Research Funding to JCU is shown by funding source and project.

Queensland Health - Senior Clinical Research Fellowships

Peripheral Arterial Disease

Indicative Funding
$4,250,000 over 8 years
Developing novel therapies ad management pathways for Peripheral Arterial Disease. Aim 1. to assess the safety and efficacy of novel medications for PAD within carefully designed clinical trials and registries; Aim 2. to utilise clinical risk factors and novel biomarkers to develop models to better predict outcomes for PAD: Aim 3. To develop appropriate guidelines for the evidence-based management of PAD in Australia and assess novel ways to implement them within Queensland.
Jonathan Golledge in collaboration with Paul Norman, Timothy Buckenham, Robert Fitridge, Bernard Bourke, Mark Nelson, Reinhold Muller, Anthony Leicht, Frances Quirk, Paula Clancy, Erik Biros, Corey Moran, Lesley Stainkey, Phillip Walker, Craig McLachlan, Yew Toh Wong and Melina Wilson (College of Medicine & Dentistry, The University of Western Australia, Christchurch Hospital, Queen Elizabeth Hospital, Gosford Hospital, Menzies School of Health Research, College of Public Health, Medical & Vet Sciences, College of Healthcare Sciences, Townsville - Mackay Medicare Local, The University of Queensland, University of Technology, Sydney, Southmead Hospital, Bristol and St George's Hospital Medical School)
Peripheral Arterial Disease

NHMRC - Practitioner Fellowship

Developing improved management for peripheral artery diseases

Indicative Funding
$569,219 over 5 years
This fellowship aims to address current deficiencies in the care of PAD patients by: Aim 1: Testing new PAD treatments in patient-relevant pre-clinical models; Aim 2: Examining the efficacy of new treatments in human clinical trials; Aim 3: Discovering novel targets for diagnostic tests, prognostic markers and treatments.
Jon Golledge (College of Medicine & Dentistry)
Peripheral Arterial Disease; Aortic Aneurysm

Queensland Health - Junior Research Fellowship

Coding and non-coding circulating RNAs associated with the presence and rapid expansion of abdominal aortic aneurysms

Indicative Funding
$250,000 over 2 years
Deoxyribonucleic Acid, or DNA is the molecule that comprises genes. The mix of genes you have may mean you are likely to have, or be more prone to develop, particular conditions. The way the information encoded by DNA is converted into outcomes (such as a medical condition) is via the action of Ribonucleic Acid, or RNA. This project aims to identify RNAs in blood associated with the presence or rapid growth of abdominal aortic aneurysms - potentially lethal balloonings of the largest artery in the abdomen, the abdominal aorta. This may yield new methods of diagnosing and treating aneurysms.
Vikram Iyer and Jon Golledge (College of Medicine & Dentistry)
Abdominal Aortic Aneurysm; RNAs

NHMRC - Project Grant

Blocking the factor XII-kallikrein pathway to limit abdominal aortic aneurysm

Indicative Funding
$686,995 over 3 years
Abdominal aortic aneurysm (AAA) is estimated to be responsible for 2000 sudden deaths each year in Australia. AAAs can be readily identified when they are small but there are currently no effective medical therapies to limit complications in patients that have such AAAs. We hypothesise that interventions inhibiting the FXII-kallikrein pathway will limit progression of established AAAs within pre-clinical models and have other important secondary benefits such as the reduction of atherosclerosis progression.
Jon Golledge and Corey Moran in collaboration with Daniel Sexton, Rhondda Jones, Paul Norman and Kosta Panousis (College of Medicine & Dentistry, Dyax Corporation, Division of Tropical Health & Medicine, The University of Western Australia and CSL)
Abdominal Aortic Aneurysm; mouse models; Peripheral Vascular Disease; Biology; treatment planning

NHMRC - Project Grant

Upregulating kallistatin to limit abdominal aortic aneurysm

Indicative Funding
$648,021 over 3 years
Abdominal aortic aneurysms are present in ~100,000 Australians and easily identified at an early stage. Currently there is no effective treatment for small aneurysms since early surgical therapies do not improve outcomes and there are currently no effective drugs which inhibit aortic aneurysm progression. Patients with small aneurysms are simply managed by repeat imaging at intervals but up to 70% of small aneurysms later expand to a size requiring surgery. Repeat imaging and surgery of abdominal aortic aneurysm are estimated to cost Australia ~$80 million/ year. We present preliminary data suggesting that the protein kallistatin can inhibit aneurysm progression and that it can be upregulated by the drug fenofibrate. The aim of the current study are to assess if mice overexpressing kallistatin are protected from abdominal aortic aneurysm and if administration of 145mg of fenofibrate can increase serum kallistatin in patients with small abdominal aortic aneurysms. We will assess these hypotheses in mice models and within a randomized controlled trial of patients that have small abdominal aortic aneurysms. We have established appropriate mice models, reproducible outcome assessments methods and identified patients to examine these aims. This study represents vital next steps in the assessment of a potential new medical therapy target for abdominal aortic aneurysm.
Jon Golledge and Phillip Walker in collaboration with Bernard Bourke, Christopher Reid and Jiang-Xing Ma (College of Medicine & Dentistry, The University of Queensland, Gosford Hospital, Monash University and Oklahoma State University - Stillwater)
Peripheral Arterial Disease; Aortic Aneurysm

NHMRC - Project Grant

Assessment of the Efficacy of a Brief Behaviour Intervention Designed to Improve Physical Activity in Patients with Peripheral Artery Disease

Indicative Funding
$662,912 over 5 years
The primary aim of the current study is to assess the efficacy of a Brief Behavioural Intervention (BBI) delivered by allied health workers in health facilities to improve physical activity in patients with PAD over 24 months. Secondary aims of this study are to examine the effect of the BBI on participants functional capacity, revascularisation rate, resource use, and to perform an economic evaluation of the BBI compared to usual care.
Jon Golledge, Nicola Burton, Phil Walker, Paul Norman, Anthony Leicht and Zanfina Ademi in collaboration with Richard Holdsworth, Ronan O'Carroll, Belinda Parmenter and Christopher Reid (College of Medicine & Dentistry, The University of Queensland, The University of Western Australia, College of Healthcare Sciences, The University of Melbourne, Forth Valley Royal Hospital, University of Stirling, The University of New South Wales and Monash University)
Peripheral Arterial Disease; Physical Activity; Intermittent Claudication; Behavioural Medicine

NHMRC - Project Grant

The Role of Angiotensin converting enzyme in limiting complications of aortic aneurysm

Indicative Funding
$663,475 over 3 years
Bursting or tearing of the main artery leading from the heart kills approximately 1300 Australians each year. In this study we will assess the role of a novel pathway in artery weakening. Improved understanding of he mechanisms causing artery degeneration is crucial to develop better ways to treat this common problem.
Jon Golledge, Christos Tikellis and Phillip Walker in collaboration with Paul Norman, Merlin Thomas and Carla Ewels (College of Medicine & Dentistry, Baker Heart & Diabetes Institute, The University of Queensland, The University of Western Australia, College of Public Health and Medical & Vet Sciences)
Peripheral Arterial Disease; Aortic Aneurysm

Heart Foundation - Vanguard Grant

Association of Vitamin D insufficiency with presence, growth and biomarkers of abdominal aortic aneurysm

Indicative Funding
In this study we examine if vitamin D insufficiency is associated with aortic aneurysm presence and growth and investigate likely mechanisms by which this may occur.
Jon Golledge, Paul Norman, Rachel Neale and Michael Clarke (College of Medicine & Dentistry, The University of Western Australia and Queensland Institute of Medical Research)
Abdominal Aortic Aneurysm; Vitamin D; Cardiovascular

NHMRC - Project Grant

Telmisartan in the management of abDominal aortic aneurYsm (TEDY)

Indicative Funding
$1,105,894 over 5 years
Approximately 5% of men and 1% of women aged over 60 years develop weakening of the main abdominal artery. Currently the management of artery weakening is focused on surgery with no effective medications available. In this trial we will examine the value of a promising drug therapy. If proved effective this medication could reduce the requirement for surgery by controlling artery weakening at an early stage in its development.
Jonathan Golledge, Paul Norman, Phillip Walker, Anna Ahimastos, Ronald Dalman, Robert Fitridge, Andrew Tonkin, Christopher Reid, Reinhold Muller, Frank Quigley, Graeme Hankey, Bernard Bourke, Anthony Dear and Bronwyn Kingwell (College of Medicine & Dentistry, The University of Western Australia, The University of Queensland, Baker Heart & Diabetes Institute, Stanford University, University of Adelaide, Monash University, College of Public Health, Medical & Vet Sciences and Gosford Hospital)
Abdominal aortic aneurysm; Pathogenesis; thrapy; Patient management; Peripheral vascular disease; Cardiovascular Diseases

Advisory Accreditation: I can be on your Advisory Panel as a Primary or Secondary Advisor.

These Higher Degree Research projects are either current or by students who have completed their studies within the past 5 years at JCU. Linked titles show theses available within ResearchOnline@JCU.

  • Identification of Mediators Important in Determining Carotid Plaque Instability (PhD , Secondary Advisor)
  • Individualized Laparoscopic and Related Technique in Rectal Cancer Surgery (PhD , Secondary Advisor)
  • A new mouse model of lower limb ischaemia: development, validation and assessment of therapeutic targets and interventions (PhD , Primary Advisor/AM)
  • The Role of Vitamin D in the Pathogenesis and Progression of Abdominal Aortic Aneurysm. (PhD , Primary Advisor/AM)
  • Assessment and Intervention of Dietary Patterns in Patients with Peripheral Arterial Disease and Abdominal Aortic Aneurysm (PhD , Primary Advisor/AM)
  • The effects of aspects of the Mediterranean diet on Peripheral Artery Disease in mice (PhD , Primary Advisor/AM)
  • Measuring Person-Centred Healthcare (PhD , Advisor Mentor)
  • A Small Animal Model for the Creation of Intracranial Aneurysms (Masters , Secondary Advisor)

These are the most recent metadata records associated with this researcher. To see a detailed description of all dataset records, visit the JCU Research Data Catalogue.


The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.

  • 5+ collaborations
  • 4 collaborations
  • 3 collaborations
  • 2 collaborations
  • 1 collaboration
  • Indicates the Tropics (Torrid Zone)

Connect with me
Share my profile
Share my profile:

Advisory Accreditation
Advisor Mentor
Find me on…
Icon for NLA Trove People record Icon for Scopus Author page

Similar to me

  1. Dr Corey Moran
    College of Medicine & Dentistry
  2. Dr Joseph Moxon
    College of Medicine & Dentistry
  3. Dr Erik Biros
    College of Medicine & Dentistry
  4. Dr Smriti Krishna
    College of Medicine & Dentistry
  5. Dr Theophilus Emeto
    College of Public Health, Medical & Vet Sciences